Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA218913
Max Phase: Preclinical
Molecular Formula: C46H76O18
Molecular Weight: 917.10
Molecule Type: Small molecule
Associated Items:
ID: ALA218913
Max Phase: Preclinical
Molecular Formula: C46H76O18
Molecular Weight: 917.10
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CO[C@]1(CC[C@H](C)CO)O[C@H]2C[C@H]3[C@@H]4CC=C5C[C@@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O)[C@H]6O[C@@H]6O[C@@H](C)[C@H](O)[C@@H](O)[C@H]6O)CC[C@]5(C)[C@H]4CC[C@]3(C)[C@H]2[C@@H]1C
Standard InChI: InChI=1S/C46H76O18/c1-20(17-47)9-14-46(57-6)21(2)31-28(64-46)16-27-25-8-7-23-15-24(10-12-44(23,4)26(25)11-13-45(27,31)5)59-43-40(63-41-37(55)35(53)32(50)22(3)58-41)39(34(52)30(19-49)61-43)62-42-38(56)36(54)33(51)29(18-48)60-42/h7,20-22,24-43,47-56H,8-19H2,1-6H3/t20-,21-,22-,24-,25+,26-,27-,28-,29+,30+,31-,32-,33+,34+,35+,36-,37+,38+,39-,40+,41-,42-,43-,44-,45-,46+/m0/s1
Standard InChI Key: YDURWQJGBGEELH-PDGQMJSTSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: Yes | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 917.10 | Molecular Weight (Monoisotopic): 916.5032 | AlogP: -0.18 | #Rotatable Bonds: 13 |
Polar Surface Area: 276.14 | Molecular Species: NEUTRAL | HBA: 18 | HBD: 10 |
#RO5 Violations: 3 | HBA (Lipinski): 18 | HBD (Lipinski): 10 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 11.89 | CX Basic pKa: | CX LogP: 0.14 | CX LogD: 0.14 |
Aromatic Rings: 0 | Heavy Atoms: 64 | QED Weighted: 0.11 | Np Likeness Score: 2.39 |
1. Hou S, Xu P, Zhou L, Yu D, Lei P.. (2006) Synthesis and antitumor activity of icogenin and its analogue., 16 (9): [PMID:16480873] [10.1016/j.bmcl.2006.01.074] |
Source(1):